SIA
PFE icon

Strategic Investment Advisors’s Pfizer PFE Stock Holding History

Strategic Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Buy
49,294
+8,896
+22% +$237K 0.1% 110
2025
Q4 		$1.01M Sell
40,398
-2,800
-6% -$70.6K 0.09% 102
2025
Q3 		$1.1M Sell
43,198
-764
-2% -$18.9K 0.1% 95
2025
Q2 		$1.06M Sell
43,962
-3,036
-6% -$70.8K 0.1% 92
2025
Q1 		$1.19M Sell
46,998
-39,033
-45% -$1.02M 0.13% 91
2024
Q4 		$2.28M Sell
86,031
-4,293
-5% -$116K 0.24% 55
2024
Q3 		$2.61M Buy
90,324
+4,103
+5% +$120K 0.29% 53
2024
Q2 		$2.41M Buy
86,221
+732
+0.9% +$20.2K 0.29% 53
2024
Q1 		$2.37M Buy
85,489
+1,900
+2% +$52.7K 0.3% 50
2023
Q4 		$2.41M Sell
83,589
-5,165
-6% -$156K 0.35% 49
2023
Q3 		$2.94M Sell
88,754
-2,940
-3% -$104K 0.48% 40
2023
Q2 		$3.36M Sell
91,694
-2,423
-3% -$94.3K 0.47% 28
2023
Q1 		$3.84M Buy
94,117
+22,879
+32% +$988K 0.69% 26
2022
Q4 		$3.65M Buy
71,238
+3,122
+5% +$150K 0.76% 27
2022
Q3 		$2.98M Buy
68,116
+3,473
+5% +$169K 0.67% 29
2022
Q2 		$3.39M Buy
64,643
+9,401
+17% +$479K 0.68% 29
2022
Q1 		$2.86M Buy
55,242
+1,264
+2% +$65.6K 0.54% 34
2021
Q4 		$3.19M Sell
53,978
-373
-0.7% -$18.5K 0.62% 34
2021
Q3 		$2.34M Buy
54,351
+1,596
+3% +$70.7K 0.51% 38
2021
Q2 		$2.07M Buy
52,755
+257
+0.5% +$9.99K 0.47% 39
2021
Q1 		$1.9M Buy
52,498
+10,220
+24% +$363K 0.49% 43
2020
Q4 		$1.56M Buy
42,278
+20,294
+92% +$744K 0.45% 51
2020
Q3 		$763K Buy
21,984
+2,509
+13% +$88K 0.26% 74
2020
Q2 		$604K Buy
19,475
+790
+4% +$26.8K 0.23% 78
2020
Q1 		$579K Buy
18,685
+3,833
+26% +$131K 0.27% 72
2019
Q4 		$552K Buy
14,852
+6,201
+72% +$221K 0.23% 74
2019
Q3 		$295K Buy
+8,651
New +$315K 0.14% 116
2019
Q2 		– Sell
-6,222
Closed -$251K – 164
2019
Q1 		$251K Buy
6,222
+135
+2% +$5.41K 0.17% 105
2018
Q4 		$252K Buy
+6,087
New +$253K 0.23% 89

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Strategic Investment Advisors's PFE Position: Q1 2026 in Review

Strategic Investment Advisors increased its Pfizer (PFE) stake by 22% in Q1 2026, buying an estimated $237K and bringing the position to 49,294 shares worth $1.38M. The position accounts for 0.1% of the portfolio, ranked #110.

Strategic Investment Advisors first reported a position in PFE in Q4 2018 and has held it in 29 quarters since. The position peaked at $3.84M in Q1 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Strategic Investment Advisors held 49,294 shares of Pfizer worth $1.38M as of Q1 2026.
  • Strategic Investment Advisors bought 8,896 Pfizer shares in Q1 2026, an estimated $237K.
  • Pfizer made up 0.1% of Strategic Investment Advisors's portfolio in Q1 2026, its #110 holding.
  • Strategic Investment Advisors first reported a position in Pfizer in Q4 2018 and has held it in 29 quarters since.
  • Strategic Investment Advisors's Pfizer position peaked at $3.84M in Q1 2023.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Strategic Investment Advisors's 13F filing for Q1 2026, filed 18 May 2026.